Sexual Transmission Surpasses Drug Use as Cause of AIDS Among Women CDC Daily UpdateImportant note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




Sexual Transmission Surpasses Drug Use as Cause of AIDS Among Women

PR Newswire (10/13/93)


Tampa, Fla.--In Florida, and across the nation, the incidence of AIDS in women is increasing and, among women, HIV infection through heterosexual activity has bypassed injection-drug use as the most prevalent mode of contracting the virus. The Centers for Disease Control this year expanded its definition of AIDS to include women with invasive cervical cancer, an action that will probably result in an even greater increase in the number of cases reported among females. Women now account for 12 percent of reported American cases of AIDS, a climb from 7 percent in 1985, according to the CDC. In addition, the mortality rate for women with AIDS is growing quickly. About one-quarter of infected women in 1992 were diagnosed between the ages of 20 and 29. Because the average period of latency between HIV infection and development of AIDS is 10 years, this CDC statistic implies that many of the women were infected during their teenage years. Other data for 1992 indicate that 54 percent of American women with AIDS were black, 23 percent were white, and 21 percent were Hispanic.


931015
AD931864


Copyright © 1993 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.